Anaphylaxis and Systemic Mastocytosis Controlled with KIT Inhibitors in a Patient with Metastatic Lung Adenocarcinoma.

Camellia L. Hernandez,Donna‐Marie Lynch,Abby Jane Golash,Kathleen Marquis, Kylie Marie Besz,Geoffrey Oxnard,Julia Rotow,Daniel J. DeAngelo,Mariana Castells

Annals of allergy, asthma, & immunology（2023）

引用 0|浏览10

暂无评分

摘要

A 58‐year‐old female with indolent systemic mastocytosis (ISM) and metastatic non‐ small cell lung cancer (NSCLC) presented with anaphylaxis to osimertinib with three attempts at rapid drug desensitization (RDD).

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要